#521 on the rich list of 14,644 insiders
Keith Manchester
Director at Roivant Sciences; Director at Arbutus Biopharma.
$447M
in disclosed stock, +$5.3M (+1.20%) today
Live prices, last trade 2:32 PM ET
- Rank
- 521st of 14,644
- Companies held
- 2
- Largest holding
- ROIV, 100.0% of total
- Latest SEC filing
- Nov 17, 2026
What the $447M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Roivant Sciences ROIV Common Shares | Held by QVT Financial Investment Cayman Ltd. Reported jointly by 2 insiders; split evenly | 6,749,547 | $39.20 | $265M | 59.2% | Form 4, Nov 17, 2026 |
| Roivant Sciences ROIV Common Shares | Held by QVT Deferred Compensation Holdings Ltd. Reported jointly by 2 insiders; split evenly | 2,902,731 | $39.20 | $114M | 25.4% | Form 4, Nov 17, 2026 |
| Roivant Sciences ROIV Common Shares | Directly | 1,753,457 | $39.20 | $68.7M | 15.4% | Form 4, Sep 16, 2026 |
| Arbutus Biopharma ABUS Common Shares | Directly | 46,069 | $4.14 | $190K | 0.0% | Form 4, Aug 14, 2024 |
Share counts are the amounts Keith Manchester reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Sold | ROIV | 75,716 | $38.24 | $2.9M | View |
| Nov 17, 2026 | Sold | ROIV | 525,507 | $38.24 | $20.1M | View |
| Nov 17, 2026 | Sold | ROIV | 798 | $38.24 | $31K | View |
| Nov 16, 2026 | Sold | ROIV | 79,461 | $39.17 | $3.1M | View |
| Nov 16, 2026 | Sold | ROIV | 550,280 | $39.17 | $21.6M | View |
| Nov 16, 2026 | Sold | ROIV | 18,927 | $38.99 | $738K | View |
| Nov 16, 2026 | Sold | ROIV | 131,073 | $38.99 | $5.1M | View |
| Jun 30, 2026 | Sold | ROIV | 200,000 | $35.45 | $7.1M | View |
| Jun 30, 2026 | Sold | ROIV | 12,380 | $35.28 | $437K | View |
| Jun 29, 2026 | Sold | ROIV | 600,000 | $34.59 | $20.8M | View |
| Jun 29, 2026 | Sold | ROIV | 200,000 | $34.44 | $6.9M | View |
| Jun 26, 2026 | Sold | ROIV | 325,000 | $34.07 | $11.1M | View |
| Jun 26, 2026 | Sold | ROIV | 300,783 | $33.92 | $10.2M | View |
| Feb 13, 2026 | Sold | ROIV | 150,784 | $26.49 | $4.0M | View |
| Feb 13, 2026 | Sold | ROIV | 225,000 | $26.50 | $6.0M | View |
| Feb 12, 2026 | Sold | ROIV | 275,000 | $26.76 | $7.4M | View |
| Feb 12, 2026 | Sold | ROIV | 150,000 | $26.72 | $4.0M | View |
| Feb 11, 2026 | Sold | ROIV | 425,000 | $26.67 | $11.3M | View |
| Dec 17, 2025 | Sold | ROIV | 189,538 | $23.17 | $4.4M | View |
| Dec 17, 2025 | Sold | ROIV | 432,718 | $23.05 | $10.0M | View |
| Dec 17, 2025 | Sold | ROIV | 155,076 | $23.02 | $3.6M | View |
| Dec 16, 2025 | Sold | ROIV | 275,000 | $22.93 | $6.3M | View |
| Dec 16, 2025 | Sold | ROIV | 642,282 | $23.08 | $14.8M | View |
| Nov 19, 2025 | Sold | ROIV | 850,000 | $20.25 | $17.2M | View |
| Nov 19, 2025 | Sold | ROIV | 150,000 | $20.20 | $3.0M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 518 | Lawrence James Lawson III Director, Lincoln International. Chicago, IL | $450M |
| 519 | Noubar B. Afeyan Director, Moderna. Cambridge, MA | $447M |
| 520 | Dean Solon 10% owner, Shoals Technologies Group. Portland, TN | $447M |
| 521 | Keith Manchester Director, Roivant Sciences | $447M |
| 522 | Raul Marcelo Claure Director, T-Mobile US. Bellevue, WA | $446M |
| 523 | Michael Ho Chief Strategy Officer, Hut 8. Miami, FL | $445M |
| 524 | Yair Nechmad CEO, Co Founder & Chairman, Nayax | $445M |
Other Roivant Sciences insiders
All ROIV insiders- Dan Oren$4.03B10% owner. #78 overall
- Vivek Ramaswamy$1.84B10% owner. #153 overall
- Daniel Allen Gold$730MDirector. #278 overall
- Mayukh Sukhatme$721MPresident & CIO. #350 overall
- Matthew Gline$642MCEO. #334 overall
- Frank Torti$482MPresident and Vant Chair. #476 overall
Questions
How much stock does Keith Manchester own?
Keith Manchester holds $447,238,239 in listed stock based on SEC filings and current prices, mostly Roivant Sciences (ROIV). That ranks 521st on the Stock Rich List.
Is this Keith Manchester's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Keith Manchester last buy or sell stock?
The most recent open-market trade on file is a sale of 75,716 ROIV shares on Nov 17, 2026 at $38.24.